Use este identificador para citar ou linkar para este item:
http://hdl.handle.net/1843/57817| Tipo: | Artigo de Periódico |
| Título: | Dealing with cancer screening in the covid-19 era |
| Autor(es): | Thales Pardini Fagundes Ronniel Morais Albuquerque Diego Lopes Paim Miranda Luciana Castro Garcia Landeiro Gabriel Souza Fontes Ayres Caenna Corrêa e Correia Angélica Nogueira Rodrigues |
| Resumo: | OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19. |
| Assunto: | Detecção Precoce de Câncer Pandemias Infecções por Coronavirus |
| Idioma: | eng |
| País: | Brasil |
| Editor: | Universidade Federal de Minas Gerais |
| Sigla da Instituição: | UFMG |
| Departamento: | MED - DEPARTAMENTO DE CLÍNICA MÉDICA |
| Tipo de Acesso: | Acesso Aberto |
| Identificador DOI: | 10.1590/1806-9282.67 |
| URI: | http://hdl.handle.net/1843/57817 |
| Data do documento: | 2021 |
| metadata.dc.url.externa: | http://https://www.scielo.br/j/ramb/a/5cXbV6J5xSB6mnPCs68X4nz/?lang=endoi:10.1590/1806-9282.67 |
| metadata.dc.relation.ispartof: | Revista da Associação Médica Brasileira |
| Aparece nas coleções: | Artigo de Periódico |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Dealing with cancer screening in the COVID-19 era pdfa.pdf | 217 kB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.